OXFORD ASSET MANAGEMENT LLP - NABRIVA THERAPEUTICS PLC ownership

Back to all holdings Add to watchlist

NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 54 filers reported holding NABRIVA THERAPEUTICS PLC in Q1 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q4 2019$271,000
+59.4%
205,423
+76.7%
0.01%
+100.0%
Q4 2018$170,000
+24.1%
116,234
+125.2%
0.00%
+33.3%
Q3 2018$137,000
-38.6%
51,622
-19.7%
0.00%
-25.0%
Q2 2018$223,000–64,313–0.00%–
 Download
Other shareholders
NABRIVA THERAPEUTICS PLC shareholders Q1 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 191,028$462,0000.08%
Sterling Investment Advisors, Ltd. 5,000$12,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of NABRIVA THERAPEUTICS PLC shareholders